THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...
BeiGene (BGNE), a global oncology company that intends to change its name to BeOne Medicines, announced the U.S. FDA has approved Tevimbra in ...
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
BeiGene (BGNE) announced the FDA has approved TEVIMBRA, in combination with platinum and fluoropyrimidine-based chemotherapy, for the ...